Free Trial

Purus Wealth Management LLC Sells 1,475 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Intuitive Surgical logo with Medical background

Purus Wealth Management LLC reduced its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.5% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 25,292 shares of the medical equipment provider's stock after selling 1,475 shares during the period. Intuitive Surgical makes up 5.2% of Purus Wealth Management LLC's portfolio, making the stock its 3rd largest holding. Purus Wealth Management LLC's holdings in Intuitive Surgical were worth $13,201,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Godsey & Gibb Inc. boosted its stake in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after buying an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical during the 3rd quarter valued at approximately $33,000. Decker Retirement Planning Inc. purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at $36,000. Capital Performance Advisors LLP bought a new stake in Intuitive Surgical in the third quarter worth $38,000. Finally, DT Investment Partners LLC raised its stake in Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider's stock valued at $40,000 after purchasing an additional 36 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Activity

In related news, SVP Mark Brosius sold 2,128 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the sale, the senior vice president now owns 273 shares of the company's stock, valued at $140,595. This represents a 88.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 48,190 shares of company stock worth $25,012,927. 0.80% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities analysts have commented on ISRG shares. Mizuho lifted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Citigroup upped their price objective on Intuitive Surgical from $567.00 to $640.00 and gave the company a "buy" rating in a research report on Wednesday, December 11th. Piper Sandler reiterated an "overweight" rating and issued a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Royal Bank of Canada increased their price target on Intuitive Surgical from $525.00 to $555.00 and gave the company an "outperform" rating in a report on Friday, October 18th. Finally, Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research report on Thursday, December 5th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average price target of $554.17.

Read Our Latest Stock Analysis on Intuitive Surgical

Intuitive Surgical Stock Up 1.5 %

NASDAQ:ISRG traded up $8.56 during mid-day trading on Monday, reaching $592.64. The company's stock had a trading volume of 2,630,118 shares, compared to its average volume of 1,158,623. Intuitive Surgical, Inc. has a 1 year low of $362.14 and a 1 year high of $597.68. The stock has a fifty day moving average of $540.66 and a 200-day moving average of $499.64. The firm has a market capitalization of $211.09 billion, a PE ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Recommended Stories

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Should You Invest $1,000 in Intuitive Surgical Right Now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines